Literature DB >> 637839

Metabolic effects of pent-4-enoate in isolated perfused rat heart.

J K Hiltunen.   

Abstract

The metabolic effects of the hypoglycaemic agent pent-4-enoate were studied in isolated, beating or potassium-arrested rat hearts. The addition of 0.8mM-pent-4-enoate to the perfusion fluid increased O2 consumption by 76% in the arrested heart and by 14% in the beating heart; the concentration ratio of phosphocreatine/creatine increase concomitantly by 47% and 27% respectively. Perfusion of the heart with pent-4-enoate resulted in a 30-fold increase in the concentration of the pool of tricarboxylic acid-cycle intermediates in the tissue, about 90% of this increase being due to malate. The sum of the concentrations of the myocardial free amino acids remained virtually unchanged during the accumulation of the tricarboxylic acid-cycle intermediates. It was concluded that pent-4-enoate can be effectively metabolized in the myocardium and that its metabolism probably proceeds via propionyl-CoA, since pent-4-enoate reproduces many of the metabolic characteristics of propionate in the cardiac muscle. The accumulation of the tricarboxylic acid-cycle intermediates is probably due to carboxylation of propionyl-CoA. The response pattern of the metabolite concentrations in the cardiac muscle is quite different from that in the liver, in which decrease of the concentrations of the tricarboxylic acid-cycle intermediates has been observed previously [Williamson, Rostand & Peterson (1970) J. Biol. Chem. 245, 3242-3251].

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 637839      PMCID: PMC1183890          DOI: 10.1042/bj1700241

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  [A simple technic for extremely rapid freezing of large pieces of tissue].

Authors:  A WOLLENBERGER; O RISTAU; G SCHOFFA
Journal:  Pflugers Arch Gesamte Physiol Menschen Tiere       Date:  1960

2.  Mitochondrial-cytosolic interactions in perfused rat heart. Role of coupled transamination in repletion of citric acid cycle intermediates.

Authors:  B Safer; J R Williamson
Journal:  J Biol Chem       Date:  1973-04-10       Impact factor: 5.157

3.  Control factors affecting gluconeogenesis in perfused rat liver. Effects of 4-pentenoic acid.

Authors:  J R Williamson; S G Rostand; M J Peterson
Journal:  J Biol Chem       Date:  1970-06       Impact factor: 5.157

4.  On the mechanism of inhibition of fatty acid oxidation by 4-pentenoic acid in rat liver mitochondria.

Authors:  M H Fukami; J R Williamson
Journal:  J Biol Chem       Date:  1971-03-10       Impact factor: 5.157

5.  Regulation of glucose uptake by muscles. 10. Effects of alloxan-diabetes, starvation, hypophysectomy and adrenalectomy, and of fatty acids, ketone bodies and pyruvate, on the glycerol output and concentrations of free fatty acids, long-chain fatty acyl-coenzyme A, glycerol phosphate and citrate-cycle intermediates in rat heart and diaphragm muscles.

Authors:  P B Garland; P J Randle
Journal:  Biochem J       Date:  1964-12       Impact factor: 3.857

6.  Malic enzymes of rabbit heart mitochondria. Separation and comparison of some characteristics of a nicotinamide adenine dinucleotide-preferring and a nicotinamide adenine dinucleotide phosphate-specific enzyme.

Authors:  R C Lin; E J Davis
Journal:  J Biol Chem       Date:  1974-06-25       Impact factor: 5.157

7.  Biochemical effects of the hypoglycaemic compound pent-4-enoic acid and related non-hypoglycaemic fatty acids. Effects of the free acids and their carnitine esters on coenzyme A-dependent oxidations in rat liver mitochondria.

Authors:  P C Holland; H S Sherratt
Journal:  Biochem J       Date:  1973-09       Impact factor: 3.857

8.  METABOLISM OF PROPIONATE BY SHEEP LIVER. OXIDATION OF PROPIONATE BY HOMOGENATES.

Authors:  R M SMITH; W S OSBORNE-WHITE
Journal:  Biochem J       Date:  1965-05       Impact factor: 3.857

9.  On the mechanism of malonyl-CoA-independent fatty acid synthesis. I. The mechanism of elongation of long-chain fatty acids by acetyl-CoA.

Authors:  W Seubert; I Lamberts; R Kramer; B Ohly
Journal:  Biochim Biophys Acta       Date:  1968-12-18

10.  Energy-linked regulation of glucose and pyruvate oxidation in isolated perfused rat heart. Role of pyruvate dehydrogenase.

Authors:  J K Hiltunen; I E Hassinen
Journal:  Biochim Biophys Acta       Date:  1976-08-13
View more
  7 in total

1.  Effects of pent-4-enoate on cellular redox state, glycolysis and fatty acid oxidation in isolated perfused rat heart.

Authors:  J K Hiltunen; V P Jauhonen; M J Savolainen; I E Hassinen
Journal:  Biochem J       Date:  1978-02-15       Impact factor: 3.857

2.  The mechanism of ammonia production and the effect of mechanical work load on proteolysis and amino acid catabolism in isolated perfused rat heart.

Authors:  T Takala; J K Hiltunen; I E Hassinen
Journal:  Biochem J       Date:  1980-10-15       Impact factor: 3.857

3.  Isolated rat heart mitochondria are able to metabolize pent-4-enoate to tricarboxylic acid-cycle intermediates.

Authors:  J K Hiltunen; R A Kauppinen; E M Nuutinen; K J Peuhkurinen; I E Hassinen
Journal:  Biochem J       Date:  1980-06-15       Impact factor: 3.857

4.  Pyruvate carboxylation as an anaplerotic mechanism in the isolated perfused rat heart.

Authors:  K J Peuhkurinen; I E Hassinen
Journal:  Biochem J       Date:  1982-01-15       Impact factor: 3.857

5.  Elimination and replenishment of tricarboxylic acid-cycle intermediates in myocardium.

Authors:  E M Nuutinen; K J Peuhkurinen; E P Pietiläinen; J K Hiltunen; I E Hassinen
Journal:  Biochem J       Date:  1981-03-15       Impact factor: 3.857

6.  Metabolism of pent-4-enoate in rat heart. Reduction of the double bond.

Authors:  J K Hiltunen; E J Davis
Journal:  Biochem J       Date:  1981-02-15       Impact factor: 3.857

7.  Caenorhabditis elegans F09E10.3 encodes a putative 3-oxoacyl-thioester reductase of mitochondrial type 2 fatty acid synthase FASII that is functional in yeast.

Authors:  Aner Gurvitz
Journal:  J Biomed Biotechnol       Date:  2009-09-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.